Vaccines in the 21st Century
A special issue of Vaccines (ISSN 2076-393X). This special issue belongs to the section "Human Vaccines and Public Health".
Deadline for manuscript submissions: closed (31 October 2023) | Viewed by 3353
Special Issue Editor
Interests: microbiology; bioinformatics; soil microbiome; cell stress; microbial symbiosis; cyanobacteria
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
The 21st century has experienced several outbreaks, impacting human health like never before. The long list includes COVID-19, Ebola virus disease, severe acute respiratory syndrome (SARS), H1N1 influenza, monkeypox, zika virus, and nipa virus.
The scientific community, on the contrary, has been working relentlessly on finding solutions and has developed successful vaccines. This Special Issue aims to attract high-quality, cutting-edge research on all facets of vaccine research including, but not limited to, vaccine development, delivery strategies, molecular and immunological mechanisms of vaccines, vaccine safety, and effectiveness against newer evolving diseases during the last two decades.
We are seeking original articles, review articles, systematic reviews, communications, perspectives, case and brief reports, and all other article types as accepted by the journal. All manuscripts will undergo a rigorous peer-review process.
We look forward to receiving your quality contributions to this Special Issue.
Dr. Soumyadev Sarkar
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Vaccines is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2700 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- vaccine
- vaccination
- vaccine development
- vaccine design
- vaccine safety
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- Reprint: MDPI Books provides the opportunity to republish successful Special Issues in book format, both online and in print.
Further information on MDPI's Special Issue policies can be found here.
